CDC Backs Twice-Yearly Injectable for HIV Prevention

(MedPage Today) — The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir (Yeztugo) for HIV pre-exposure prophylaxis (PrEP), but will that ensure the treatment’s place in the nation…